The University of Ghana (UG), in collaboration with Google Research Africa and the University College of London’s (UCL) ...

Neurosense Therapeutics (NASDAQ:NRSN) is developing novel treatments for neurodegenerative diseases like amyotrophic lateral ...

ATH-1105 – A next-generation, novel, orally administered, small molecule drug candidate in development for the potential treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A and ...

Ben Baldanza, who helped pioneer discount air travel as head of Spirit Airlines Inc. and became a target of passenger ...

ARLINGTON, Virginia—Ben Baldanza, former president and CEO of U.S. ULCC Spirit Airlines, died Nov. 5 after a long battle with ...

NeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe ...

Ben Baldanza, who worked four decades in the US airline industry and helped create the ultra-low-cost model as former chief ...

Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...

Ben Baldanza, the former CEO of Spirit Airlines, died on Tuesday following a battle with ALS. He was 62 years old.